PedAM
Pediatric Disease Annotations & Medicines
| Disease | schizophrenia |
| Phenotype | C0006868|cannabis abuse |
| Sentences | 6 |
| PubMedID- 22907121 | We performed a systematic review including structural magnetic resonance imaging studies comparing high-risk and schizophrenia patients with and without cannabis abuse and found inconclusive results. |
| PubMedID- 19997844 | First-episode schizophrenia patients with comorbid cannabis abuse (sz-sud) showed significantly enhanced facilitation (facilitatory isi of 15 ms; higher ratio, conditioned mep/unconditioned mep; mean, 95% ci) compared to patients without previous cannabis abuse (sz-nsud) in right motor cortex (z = −2.0, p = 0.047; mann–whitney u test). |
| PubMedID- 25471704 | Methods: we enrolled patients experiencing an acute psychotic episode, affected either by schizophrenia with or without cannabis abuse (scz +/- ca; n = 5 and n = 5, respectively) with recent onset (<5 years of illness) or by sipd (n = 6), as diagnosed by the structured clinical interview for dsm-iv axis i. |
| PubMedID- 24478729 | Conversely, schizophrenia patients with past cannabis abuse had slightly better neurocognitive functioning compared to patients without past cannabis abuse. |
| PubMedID- 23970971 | Accordingly, we performed a functional magnetic resonance imaging (fmri) study of visuospatial abilities in 14 schizophrenia patients with cannabis abuse (dd), 14 nonabusing schizophrenia patients (scz), and 21 healthy controls (hcs). |
| PubMedID- 23906663 | Accordingly, we performed a functional magnetic resonance imaging study of emotional memory in schizophrenia patients with cannabis abuse (dual-diagnosis, dd). |
Page: 1